Sangamo BioSciences Inc. | Key People and Executives
Alexander Macrae
President, Chief Executive Officer & Director
Joseph S. Zakrzewski
Independent Director
Roger A. Jeffs
Independent Director
Robert F. Carey
Independent Director
H. Stewart Parker
Independent Director
Saira Ramasastry
Independent Director
Stephen George Dilly
Independent Director
Steven J. Mento
Independent Director
Alexander Macrae
President, Chief Executive Officer & Director
Kathy Yi
CFO, Principal Accounting Officer & Senior VP
Edward J. Rebar
Chief Technology Officer & Senior Vice President
Edward R. Conner
Chief Medical Officer & Senior Vice President
Andy Ramelmeier
Chief Manufacturing & Quality Officer, Senior VP
Leslie Mesones
Vice President-Human Resources
McDavid Stilwell
Vice President-Corporate Communication
Heather Erickson
Chief of Staff
Heather D. Turner
Senior Vice President & General Counsel
Shirley M. Clift
Vice President-Regulatory Affairs
Joseph S. Zakrzewski
Independent Director
Roger A. Jeffs
Independent Director
Robert F. Carey
Independent Director
H. Stewart Parker
Independent Director
Saira Ramasastry
Independent Director
Stephen George Dilly
Independent Director
Steven J. Mento
Independent Director
| Address |
Point Richmond Tech Center II
Richmond California 94804
United States
|
|
Employees
|
- |
| Website |
http://www.sangamo.com |
| Updated |
07/08/2019 |
| Sangamo Therapeutics, Inc. researches and develops transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. |
